Kiromic BioPharma Inc. (KRBP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kiromic BioPharma Inc.

    OTC: KRBP · Real-Time Price · USD
    0.20
    0.00 (0.05%)
    At close: Mar 24, 2025, 3:59 PM

    Kiromic BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -26.9M -20.95M -34.73M -25.59M
    Depreciation & Amortization
    		 2.23M 2.22M 1.67M 469.8K
    Stock-Based Compensation
    		 597K 141.3K 1.24M 3.76M
    Other Working Capital
    		 -339K 1.82M 562.9K -710.6K
    Other Non-Cash Items
    		 4.41M 574.8K 3.7M 324.2K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 198K -3.21M 4.37M 710.3K
    Operating Cash Flow
    		 -19.46M -21.23M -23.75M -20.32M
    Capital Expenditures
    		 -366K -206.6K -4.88M -1.89M
    Cash Acquisitions
    		 n/a n/a 15K 84K
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a 15K -372K
    Investing Cash Flow
    		 -366K -206.6K -4.87M -1.81M
    Debt Repayment
    		 n/a 23.44M 4.1M 92.2K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 18.41M -111.2K -200K -2.76M
    Financial Cash Flow
    		 18.41M 23.99M 3.9M 37.34M
    Net Cash Flow
    		 -1.41M 2.56M -24.71M 15.2M
    Free Cash Flow
    		 -19.82M -21.43M -28.63M -22.22M

    Add to Watchlist